Head-to-head · WeighScore
Cora Health vs Ivy Rx
By GLP-1 ScorecardUpdated
Score comparison
Cora Health has the higher recorded score — 72.5/100 to 66.8/100.
Cora Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Cora Health | Ivy Rx |
|---|---|---|
| WeighScore | 72.5/100 | 66.8/100 |
| Grade | C | C |
| Site position | #87 | #200 |
| Semaglutide | $175/mo | $175/mo (starting dose, compounded) |
| Tirzepatide | $225/mo | $275/mo (starting dose, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #87 · C
Strengths
- Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
- Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
- LegitScript Certified (seal ID 49690100 in footer)
- Flat per-tier pricing — no dose-escalation surcharge
- Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide
What to consider
- Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
- Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
- Lowest advertised prices require 12-month commitment with no partial refunds
- No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
- Founder names and funding undisclosed on site
Site position #200 · C
Strengths
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
What to consider
- Limited public information on program details
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.